NBTK.DE vs. LYPE.DE
NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) and LYPE.DE (Amundi MSCI World Health Care UCITS ETF EUR Acc) are both Health & Biotech Equities funds - NBTK.DE tracks the Nasdaq Biotechnology while LYPE.DE tracks the MSCI World Health Care. Both are passively managed. Over the past 5 years, NBTK.DE returned 5.63%/yr vs 5.27%/yr for LYPE.DE. A 0.71 correlation means they provide meaningful diversification when combined. NBTK.DE charges 0.40%/yr vs 0.30%/yr for LYPE.DE.
Performance
NBTK.DE vs. LYPE.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NBTK.DE achieves a 4.27% return, which is significantly higher than LYPE.DE's -2.00% return.
NBTK.DE
- 1D
- 2.92%
- 1M
- 0.38%
- YTD
- 4.27%
- 6M
- 3.76%
- 1Y
- 39.20%
- 3Y*
- 9.94%
- 5Y*
- 5.63%
- 10Y*
- —
LYPE.DE
- 1D
- 2.79%
- 1M
- 3.48%
- YTD
- -2.00%
- 6M
- -1.61%
- 1Y
- 9.70%
- 3Y*
- 2.46%
- 5Y*
- 5.27%
- 10Y*
- 7.45%
NBTK.DE vs. LYPE.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 4.27% | 18.60% | 4.57% | 2.51% | -6.11% | 7.46% | 14.59% | 17.24% |
LYPE.DE Amundi MSCI World Health Care UCITS ETF EUR Acc | -2.00% | 2.17% | 7.03% | -0.27% | -0.17% | 30.38% | 2.44% | 11.90% |
Correlation
The correlation between NBTK.DE and LYPE.DE is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.71 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.65 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.68 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2019 | 0.71 |
The correlation between NBTK.DE and LYPE.DE has been stable across timeframes, ranging from 0.65 to 0.71 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBTK.DE vs. LYPE.DE — Risk / Return Rank
NBTK.DE
LYPE.DE
NBTK.DE vs. LYPE.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NBTK.DE | LYPE.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.34 | ||
| Sortino ratioReturn per unit of downside risk | +1.74 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.13 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 6.16 | 0.93 | +5.24 |
| Martin ratioReturn relative to average drawdown | 17.06 | 2.27 | +14.79 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NBTK.DE | LYPE.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.03 | 0.68 | +1.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | 0.39 | -0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.76 | -0.34 |
Drawdowns
NBTK.DE vs. LYPE.DE - Drawdown Comparison
The maximum NBTK.DE drawdown since its inception was -30.99%, which is greater than LYPE.DE's maximum drawdown of -25.95%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and LYPE.DE.
Loading charts...
Drawdown Indicators
| NBTK.DE | LYPE.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.99% | -25.95% | -5.04% |
Max Drawdown (1Y)Largest decline over 1 year | -6.24% | -10.21% | +3.97% |
Max Drawdown (3Y)Largest decline over 3 years | -29.35% | -21.30% | -8.05% |
Max Drawdown (5Y)Largest decline over 5 years | -30.99% | -21.30% | -9.69% |
Max Drawdown (10Y)Largest decline over 10 years | — | -25.95% | — |
Current DrawdownCurrent decline from peak | -1.44% | -8.75% | +7.31% |
Average DrawdownAverage peak-to-trough decline | -10.62% | -5.06% | -5.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.26% | 4.18% | -1.92% |
Volatility
NBTK.DE vs. LYPE.DE - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) has a higher volatility of 6.41% compared to Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) at 4.96%. This indicates that NBTK.DE's price experiences larger fluctuations and is considered to be riskier than LYPE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBTK.DE | LYPE.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.41% | 4.96% | +1.45% |
Volatility (6M)Calculated over the trailing 6-month period | 14.11% | 9.76% | +4.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.00% | 13.82% | +5.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.30% | 13.41% | +6.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.05% | 14.64% | +7.41% |
NBTK.DE vs. LYPE.DE - Expense Ratio Comparison
NBTK.DE has a 0.40% expense ratio, which is higher than LYPE.DE's 0.30% expense ratio.
Dividends
NBTK.DE vs. LYPE.DE - Dividend Comparison
Neither NBTK.DE nor LYPE.DE has paid dividends to shareholders.
Frequently Asked Questions
NBTK.DE and LYPE.DE have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LYPE.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LYPE.DE is cheaper with a 0.30% expense ratio, compared with 0.40% for NBTK.DE.
NBTK.DE tracks Nasdaq Biotechnology, while LYPE.DE tracks MSCI World Health Care. They also come from different issuers: Invesco and Amundi. Their fees differ too: 0.40% for NBTK.DE and 0.30% for LYPE.DE.
Find the right allocation for NBTK.DE and LYPE.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer